Nature Medicine – In the phase 2 NICHE-3 trial, patients with locally advanced mismatch repair-deficient colon cancer who were treated with neoadjuvant anti-PD1 and anti-LAG3 agents showed high…
Myeloma Paper of the Day, November 15th, suggested by Robert Orlowski / Amie L Fonder, Angela Dispenzieri, cancer, Charalampos Charalampous, David Dingli,
Peptide receptor radionuclide therapy (PRRT) has demonstrated immense promise as a treatment for patients with neuroendocrine tumors (NET) who have somatostatin receptor (SSTR) expression. PRRT…
Journal of Cancer Survivorship – Fear of cancer recurrence (FCR) is not routinely addressed in clinical practice, meaning many cancer survivors forego effective interventions. We…
We are in an era of rapid innovation and transformation in health care delivery, driven by the surging development and deployment of progressively more sophisticated…
Wafik El-Deiry: Great day of interdisciplinary learning at the LCC RNA Biology and Cancer Symposium / cancer, LCC RNA Biology and Cancer Symposium, OncoDaily,
We’re the only species that sheds emotional tears, but much about them remains an enigma.
One popular brand boasts the supplement can ‘revive whole body health’. But can an aesthetically packaged powder actually achieve that?
Concerns anti-vaccine pick for US health secretary could pursue ‘anti-science positions’ on life-saving interventions
Exclusive: Food, Farming and Countryside Commission added up cost to NHS and economy of diet-linked disease
